Adial Pharmaceuticals, Inc. (AZR) stock
AZRNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as ADIL
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q/A on Oct 21, 2026Score 5/30
Share price
Not available yet
Price, market cap and P/E appear here once daily prices are connected.
Adial Pharmaceuticals free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Adial Pharmaceuticals's free cash flow for the twelve months ending Dec 31, 2021 was -$12.01M. For fiscal 2021 it was -$12.01M.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2021 | Dec 31, 2021 | -$12.01M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2021 | Dec 31, 2021 | -$2.37M | – |
| Q3 FY2021 | Sep 30, 2021 | -$3.53M | – |
| Q2 FY2021 | Jun 30, 2021 | -$3.24M | – |
| Q1 FY2021 | Mar 31, 2021 | -$2.87M | – |